12 hours Ago
Despite exceeding Street forecasts with its Q4 2024 financials, Amarin Corporation ( NASDAQ: AMRN ) traded lower in the premarket on Wednesday as the Irish biotech announced plans to implement a ratio change in its U.S.-listed American Depositary Shares (ADS).
The company said.
